Samsara Therapeutics
  • About us
  • Our Science
    • The Lysoseeker Platform
    • Neurodegeneration
    • Rare Monogenic Disease
    • Our Pipeline
  • Insights
    • News
    • Blog
    • Publications
  • Careers
  • Contact
Select Page

Samsara Therapeutics Establishes Scientific Advisory Board

by Samsara@8529 | Jan 5, 2022 | Home, News

News Article Samsara Therapeutics Establishes Scientific Advisory Board   Michael Schlossmacher, Susan Perlman, Ed Tate and Christian Behl to help advance development of neurodegeneration and rare genetic disease therapeutics Oxford, UK and Boston, US, 06 January...

Categories

  • Blog (5)
  • Home (10)
  • News (5)

Recent Posts

  • Meet the Neuro Team – Modelling Neurodegeneration in a Dish
  • CMT Research Foundation and Samsara Therapeutics Partner on a Novel Therapeutic Approach for CMT1A
  • Meet Nicole – From Books to Bench
  • Samsara Therapeutics Establishes Scientific Advisory Board
  • More additions to the Samsara Therapeutics team

Archives

  • November 2022
  • October 2022
  • September 2022
  • January 2022
  • December 2021
  • July 2021
  • June 2021
  • February 2021
  • December 2019

Categories

  • Blog
  • Home
  • News

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org
  • Twitter
  • Instagram

Designed by Elegant Themes | Powered by WordPress